TF is involved in cancer-related processes such as tumor growth, angiogenesis, and metastasis, suggesting that variables commonly associated with an increased risk of thrombosis such as a higher clinical stage or increased cancer aggressiveness could be causing CAT via elevated TF expression [40]. This evidence concerns the gene TF and cancer.